Zostavax shingles vaccine. Courtesy photo
The litigation over the Zostavax shingles vaccine is facing another setback after a federal judge tossed the plaintiff’s only causation expert from an upcoming bellwether trial.
On Oct. 4, U.S. District Judge Harvey Bartle of the Eastern District of Pennsylvania granted Merck’s motion to exclude the testimony of plaintiff’s expert Dr. Joseph Jeret under the standards outlined in Rule 702 of the Federal Rules of Evidence and Daubert v. Merrell Dow Pharmaceuticals.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
